Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayan, K.M. V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Narayan, K.M. V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 22:34-35, 2004
© American Diabetes Association ®, Inc., 2004


Landmark Study

The Steno Diabetes Study

Reviewed by K.M. Venkat Narayan, MD, MPH, FRCP, FACP

The first 20% of the full text of this article appears below.


    STUDY
 
Gaude P, Vedel P, Larsen N, Jensen GVH, Parving H, Pedersen O: Multifactorial interventions and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393, 2003[Abstract/Free Full Text]


    SUMMARY
 
Objective. A comparison of the effect of a targeted, intensified, multifactorial intervention with that of conventional treatment on risk factors for cardiovascular disease (CVD).

Design. Randomized, open, parallel trial at the Steno Diabetes Center in Denmark.

Participants. Eighty patients with type 2 diabetes and microalbuminuria were assigned to receive conventional treatment in accordance with national guidelines, and another 80 were assigned to receive intensive treatment with stepwise implementation of behavior modification and pharmacological therapy that treated hyperglycemia, hypertension, dyslipidemia, and microalbuminuria, along with aspirin.

Primary endpoints. Death from CVD, nonfatal myocardial infarction (MI), nonfatal stroke, revascularization, and amputation.

Results. At a mean follow-up of 7.8 years, patients receiving the intensive therapy had a 53% (95% CI: 27–76%) . . . [Full Text of this Article]


    COMMENTARY
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.